FDA Seeks Input On Novel Trial Designs That Cross Therapeutic Areas

FDA will hold a public meeting on Nov. 7 to solicit ideas on ways to improve the drug development process, including through new trial designs such as master protocols that could cross multiple therapeutic areas and be implemented in the near term, the agency announced Friday (Aug. 9). The announcement came two months after Acting Commissioner Ned Sharpless said in a public interview that he wanted to help FDA modernize clinical trials and facilitate the development of non-cancer therapies. He...